Page last updated: 2024-12-11

humantenirine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

humantenirine: isolated from root of Hu-Man-Teng (Gelsemium elegans Benth.); structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11132403
CHEMBL ID3597665
MeSH IDM0131983

Synonyms (7)

Synonym
humantenirine
82375-30-2
CHEMBL3597665
CS-0131113
HY-N7508
(1r,2s,4s,7z,8r,9s)-7-ethylidene-1',6'-dimethoxyspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3'-indole]-2'-one
AKOS040760453
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1762379Analgesic activity in Kunming mouse assessed as inhibition of acetic acid-induced writhing at 5 mg/kg, ip pretreated with compound for 30 mins followed by acetic acid challenge and measured after 30 mins
AID1236142Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Geleganidines A-C, Unusual Monoterpenoid Indole Alkaloids from Gelsemium elegans.
AID1236141Cytotoxicity against rat PC12 cells assessed as inhibition of cell growth after 72 hrs by MTT assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Geleganidines A-C, Unusual Monoterpenoid Indole Alkaloids from Gelsemium elegans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]